Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MRTX | CRSP | LGND | ||
| Company | Mirati Therapeutics | Crispr Therapeutics Ag | Ligand Pharm | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 58.86 | 44.99 | 195.98 | ||
| High | 58.99 | 47.60 | 201.96 | ||
| Low | 58.54 | 44.91 | 192.96 | ||
| Latest | 58.70 | 47.57 | 199.65 | ||
| Change | -0.10 | +3.23 | +7.01 | ||
| % Change | -0.17% | +7.28% | +3.64% | ||
| Volume | 20,994,400 | 2,167,700 | 196,100 | ||
| 20-Day Average Volume | 2,385,220 | 2,346,390 | 250,035 | ||
| Previous Close | 58.80 | 44.34 | 192.64 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 58.94 | 49.90 | 205.74 | ||
| 20-Day Raw Stochastic | 17.39% | 20.93% | 27.97% | ||
| 20-Day Relative Strength | 61.06 | 44.50 | 49.51 | ||
| Weighted Alpha | -3.70 | +20.77 | +85.03 | ||
| Today's Opinion | 88% Buy | 100% Sell | 80% Buy | ||
| Previous Opinion | 88% Buy | 100% Sell | 48% Buy | ||
| Last Month's Opinion | 100% Buy | 8% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.98% since 01/12/24 | +2.46% since 03/24/26 | -1.00% since 03/24/26 | ||
| Low | 58.54 on 01/22/24 | 44.12 on 03/30/26 | 188.67 on 03/30/26 | ||
| High | 59.27 on 01/16/24 | 48.80 on 03/26/26 | 208.89 on 03/25/26 | ||
| 1-Month | |||||
| %Chg | -0.41% since 12/22/23 | -20.90% since 02/27/26 | +0.68% since 02/27/26 | ||
| Low | 58.54 on 01/22/24 | 44.12 on 03/30/26 | 188.67 on 03/30/26 | ||
| High | 59.46 on 01/12/24 | 61.00 on 03/02/26 | 227.92 on 03/11/26 | ||
| 3-Month | |||||
| %Chg | +5.42% since 10/20/23 | -13.63% since 12/26/25 | +1.95% since 12/26/25 | ||
| Low | 55.14 on 10/27/23 | 44.12 on 03/30/26 | 175.89 on 01/13/26 | ||
| High | 59.46 on 01/12/24 | 61.76 on 02/26/26 | 227.92 on 03/11/26 | ||
| 6-Month | |||||
| %Chg | +87.48% since 07/21/23 | -22.86% since 09/26/25 | +17.63% since 09/26/25 | ||
| Low | 27.30 on 08/08/23 | 44.12 on 03/30/26 | 166.10 on 09/29/25 | ||
| High | 64.41 on 10/06/23 | 78.48 on 10/08/25 | 227.92 on 03/11/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,117,688 | 4,255,975 | 3,841,433 | ||
| Shares Outstanding, K | 70,148 | 95,985 | 19,941 | ||
| Annual Sales | 12,440,000 | 3,510,000 | 268,090,000 | ||
| Annual Net Income | -740,870,000 | -581,600,000 | 124,450,000 | ||
| Last Quarter Sales | 16,400,000 | 860,000 | 59,670,000 | ||
| Last Quarter Net Income | -161,900,000 | -130,610,000 | 44,780,000 | ||
| 60-Month Beta | 0.77 | 1.71 | 1.17 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.49 on 11/06/23 | -1.37 on 02/12/26 | 2.02 on 02/26/26 | ||
| Latest Earnings Date | 02/27/24 | 05/05/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | 2.500 on 04/03/07 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 33.53 | ||